Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by (c) Franquesa, M. et al., 2012
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/34516

Immunomodulatory effect of mesenchymal stem cells on B cells

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

The research on T cell immunosuppression therapies has attracted most of the attention in clinical transplantation. However, B cells and humoral immune responses are increasingly acknowledged as crucial mediators of chronic allograft rejection. Indeed, humoral immune responses can lead to renal allograft rejection even in patients whose cell-mediated immune responses are well controlled. On the other hand, newly studied B cell subsets with regulatory effects have been linked to tolerance achievement in transplantation. Better understanding of the regulatory and effector B cell responses may therefore lead to new therapeutic approaches. Mesenchymal stem cells (MSC) are arising as a potent therapeutic tool in transplantation due to their regenerative and immunomodulatory properties.The research on MSCs has mainly focused on their effects onT cells and although data regarding the modulatory effects of MSCs on alloantigen-specific humoral response in humans is scarce, it has been demonstrated that MSCs significantly affect B cell functioning. In the present review we will analyze and discuss the results in this field.

Citació

Citació

FRANQUESA, Marcella, HOOGDUIJN, Martin johannes, BESTARD MATAMOROS, Oriol, GRINYÓ BOIRA, Josep m.. Immunomodulatory effect of mesenchymal stem cells on B cells. _Frontiers in Immunology_. 2012. Vol. 3, núm. 212. [consulta: 25 de febrer de 2026]. [Disponible a: https://hdl.handle.net/2445/34516]

Exportar metadades

JSON - METS

Compartir registre